ARCTURUS THERAPEUTICS HOLDINGS INC. Revenue Breakdown
No Revenue Breakdown for ARCT on this site yet.
- 2025-12-31: Others Not split by product in the filing$82.03M100.00%; Total revenue $82.03M.
- 2024-12-31: Others Not split by product in the filing$152.31M100.00%; Total revenue $152.31M.
- 2023-12-31: Others Not split by product in the filing$166.80M100.00%; Total revenue $166.80M.
- 2022-12-31: Others Not split by product in the filing$206.00M100.00%; Total revenue $206.00M.
Source checked: the stored Revenue Breakdown page for ARCT.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $82.03M 100.00% | $82.03M |
| 2024-12-31 | Not split by product in the filing $152.31M 100.00% | $152.31M |
| 2023-12-31 | Not split by product in the filing $166.80M 100.00% | $166.80M |
| 2022-12-31 | Not split by product in the filing $206.00M 100.00% | $206.00M |
| 2021-12-31 | Not split by product in the filing $12.36M 100.00% | $12.36M |
| 2020-12-31 | Not split by product in the filing $9.54M 100.00% | $9.54M |
| 2019-12-31 | Not split by product in the filing $20.79M 100.00% | $20.79M |
| 2018-12-31 | Not split by product in the filing $15.75M 100.00% | $15.75M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $2.96M 100.00% | $2.96M |
| 2026-03-31 | Not split by product $2.06M 100.00% | $2.06M |
| 2025-12-31 | Not split by product $7.20M 100.00% | $7.20M |
| 2025-09-30 | Not split by product $17.15M 100.00% | $17.15M |
| 2025-06-30 | Not split by product $28.30M 100.00% | $28.30M |
| 2025-03-31 | Not split by product $29.38M 100.00% | $29.38M |
| 2024-12-31 | Not split by product $22.77M 100.00% | $22.77M |
| 2024-09-30 | Not split by product $41.67M 100.00% | $41.67M |
| 2024-06-30 | Not split by product $49.86M 100.00% | $49.86M |
| 2024-03-31 | Not split by product $38.01M 100.00% | $38.01M |
| 2023-12-31 | Not split by product $30.86M 100.00% | $30.86M |
| 2023-09-30 | Not split by product $45.14M 100.00% | $45.14M |
| 2023-06-30 | Not split by product $10.52M 100.00% | $10.52M |
| 2023-03-31 | Not split by product $80.28M 100.00% | $80.28M |
| 2022-12-31 | Not split by product $160.29M 100.00% | $160.29M |
| 2022-09-30 | Not split by product $13.37M 100.00% | $13.37M |
| 2022-06-30 | Not split by product $27.09M 100.00% | $27.09M |
| 2022-03-31 | Not split by product $5.24M 100.00% | $5.24M |
| 2021-12-31 | Not split by product $5.79M 100.00% | $5.79M |
| 2021-09-30 | Not split by product $2.44M 100.00% | $2.44M |
| 2021-06-30 | Not split by product $2.00M 100.00% | $2.00M |
| 2021-03-31 | Not split by product $2.13M 100.00% | $2.13M |
| 2020-12-31 | Not split by product $2.24M 100.00% | $2.24M |
| 2020-09-30 | Not split by product $2.33M 100.00% | $2.33M |
| 2020-06-30 | Not split by product $2.32M 100.00% | $2.32M |
| 2020-03-31 | Not split by product $2.65M 100.00% | $2.65M |
| 2019-12-31 | Not split by product $2.97M 100.00% | $2.97M |
| 2019-09-30 | Not split by product $3.32M 100.00% | $3.32M |
| 2019-06-30 | Not split by product $10.15M 100.00% | $10.15M |
| 2019-03-31 | Not split by product $4.35M 100.00% | $4.35M |
| 2018-12-31 | Not split by product $7.58M 100.00% | $7.58M |
| 2018-09-30 | Not split by product $3.42M 100.00% | $3.42M |
| 2018-06-30 | Not split by product $2.39M 100.00% | $2.39M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |